Neotherapeutics, Inc.

Calculating rank

USPTO Granted Patents = 7

Forward Citations = 95

Loading Chart...

6 inventors (with patents filed for the assignee):

Alvin Jerald Glasky (7 out of 20 patents)

Jack Diamond (2 out of 2 patents)

Heinrich Bollinger (1 out of 6 patents)

4. Mark M Foreman (1 out of 3 patents)

5. Hans Rudolf Müller (1 out of 4 patents)

6. Michael P Rathbone (1 out of 2 patents)

7 patents: Sort by Forward Citations

1. 6630490 - Methods for treatment of disease-induced peripheral neuropathy and related conditions (2003-10-07),

2. 6630478 - Methods for treatment of drug-induced peripheral neuropathy (2003-10-07),

3. 6407237 - Crystal forms of 9-substituted hypoxanthine derivatives (2002-06-18),

4. 6338963 - Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis (2002-01-15),

5. 6303617 - Serotonin-like 9-substituted hypoxanthine and methods of use (2001-10-16),

6. 6297226 - Synthesis and methods of use of 9-substituted guanine derivatives (2001-10-02),

7. 6288069 - Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue (2001-09-11),

Company Overview

Neotherapeutics, Inc. is a biopharmaceutical company dedicated to developing novel therapies for unmet medical needs in oncology. The company focuses on the research and development of innovative small molecule drugs that target specific cancer pathways. With a strong pipeline of drug candidates and a commitment to improving patient outcomes, Neotherapeutics is poised to make a significant impact in the field of cancer treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#365 in Irvine, CA

#9,508 in California

#39,929 in US

Irvine, CA, United States of America